Skip to main content

Regulatory

Regulatory, Perspectives

Implications of the New Political Realities on Healthcare Reform

Assessment of Medicare Part D Communications to Beneficiaries

Meghana Aruru, PhD, MBA, BSPharm, J. Warren Salmon, PhD

Stakeholder Perspective

Medicare Part D Education Materials Must Address Recipients' Literacy Level

by Jack E. Fincham, PhD, RPh

Accountable Care Organizations in the Era of Healthcare Reform

Creating a 21st-Century Intelligent Health System

Newt Gingrich, PhD, Nancy Desmond, MEd, EdS

Stakeholder Perspective

AHDB Stakeholder Perspective

Medicare Coverage for Erythropoiesis-Stimulating Agents: The Perfect Storm

Stakeholder Perspective

UnitedHealthcare's Response to the ESA Debate

by Lee Newcomer, MD

Medicare Coverage Policies for Biologics: The Broad Gray Line

Stakeholder Perspective

CMS Coverage Policies for Biologics: Defining a Lagrangian Point for Cost, Quality, and Access

by Michael F. Murphy, MD, PhD

Medicare Coverage Strategies: Impact of the MMA and PBMs

Stakeholder Perspective

by Joseph R. Antos, PhD

Patent Reform Proposals Raise the Stakes for Researchers, Manufacturers of Biologics

Shayna B. Kravetz, BSc, Rosemary Frei, MSc

Stakeholder Perspective

AHDB Stakeholder Perspective

by Thomas McCarter, MD, FACP

The NCCN Compendium for Cancer Management

Stakeholder Perspective

Economic/Societal Costs of Adding a Compendium to the Federal Registry

by Thomas Kaye, RPh, MBA, FASHP

Cutting Through the Politics: Presidential Candidates? Healthcare Platforms and Impact on Health Benefits

Peyton Howell, MHA

Stakeholder Perspective

Health Reform and the Next President

by Joseph R. Antos, PhD

1
2
3
4

Page 3 of 4
Results 21 - 30 of 40